The National Institute of Neurological Disorders and Stroke (NINDS) awarded a $135,000 Project Grant titled "The NeuroCity Initiative: Empowering Underrepresented Scholars to Pursue Careers in Neuroscience" to the University of Rochester. This 5-year grant (12/1/2024 - 11/30/2029) under CFDA 93.853 "Extramural Research Programs in the Neurosciences and Neurological Disorders" aims to provide an immersive research experience, rigorous career development program, and continuous...
The National Institute of Neurological Disorders and Stroke (NINDS), part of the National Institutes of Health, has awarded a $189,350 Cooperative Agreement to Stanford University under the Extramural Research Programs in the Neurosciences and Neurological Disorders (CFDA 93.853) federal grant program. The purpose of this 5-year award, effective July 1, 2024, is to establish an innovative R25 training program to increase the recruitment, retention, and successful transition of diverse...
The National Institute of Neurological Disorders and Stroke (NINDS) awarded a $617,687 Project Grant (CFDA 93.853) to the University of Texas Health Science Center at Houston (UTHealth) to build infrastructure for community-engaged research interventions focused on three neurological conditions affecting brain health: stroke, vascular cognitive impairment and dementia, and Parkinson's disease. The goal is to improve understanding of factors contributing to racial and ethnic disparities in...
The University of Pittsburgh received a $215,896 Cooperative Agreement award from the National Institute of Neurological Disorders and Stroke (NINDS) under the Extramural Research Programs in the Neurosciences and Neurological Disorders (CFDA 93.853) federal grant program. The award, titled "N3-PREP (NEUROLOGY, NEUROSURGERY, & NEUROPATHOLOGY PITT RESEARCH EDUCATION PROGRAM)", will support the training of physician-neuroscientists to translate neuroscience discoveries into...
This $232,336 Project Grant award from the National Institute of Neurological Disorders and Stroke (NINDS), under the Extramural Research Programs in the Neurosciences and Neurological Disorders (CFDA 93.853) program, supports the ENLIGHTEN (Engaging Leaders in Global and Local Health Equity in Neurology) training program at the University of California, San Francisco (UCSF). The goal of ENLIGHTEN is to prepare clinician researchers and PhD scientists to become leaders in neurologic health...
This Project Grant award of $1,271,040.00 from the National Institute of Neurological Disorders and Stroke (NINDS) under the Extramural Research Programs in the Neurosciences and Neurological Disorders program (CFDA 93.853) supports innovative research at Rockefeller University aimed at discovering new therapeutic targets for neurological diseases. The key products and services to be delivered include: Developing and validating new model systems to enable unexpected discoveries about the...
This federal Project Grant award R25NS137380, totaling $179,836, is provided by the National Institute of Neurological Disorders and Stroke (NINDS) under the Extramural Research Programs in the Neurosciences and Neurological Disorders (CFDA 93.853) grant program. The award supports the Ion Channels in Synaptic and Neural Circuit Physiology Course, a three-week intensive research training program offered annually by Cold Spring Harbor Laboratory from 2024 to 2028. The primary goal of the course...
The University of New Mexico received a $630,636 Project Grant award under the National Institute of Neurological Disorders and Stroke's (NINDS) Extramural Research Programs in the Neurosciences and Neurological Disorders (CFDA 93.853) program. The award, effective July 1, 2024 through May 31, 2029, aims to investigate the genetic mechanisms regulating neural diversity in the Drosophila central complex, a brain region involved in complex behavioral control. The research will identify...
This Project Grant award from the National Institute of Neurological Disorders and Stroke (NINDS), under the Extramural Research Programs in the Neurosciences and Neurological Disorders (CFDA 93.853) program, aims to reveal the functional complexity of dis-inhibitory cortical circuits in the brain. The $435,875.00 award to the Trustees of Indiana University, awarded on Sep 20, 2024, will support research to determine the diversity of spike responses generated by genetically-defined inhibitory...
This Project Grant award from the National Institute of Neurological Disorders and Stroke (NINDS), under the Extramural Research Programs in the Neurosciences and Neurological Disorders (CFDA 93.853) program, provides $667,235.00 to the University of Virginia to conduct research on identifying genetic and epigenetic contributors to stroke and recurrent stroke risk. The project will leverage data from the Reasons for Geographic and Racial Differences in Stroke (REGARDS) study and the Vitamin...
This Project Grant award from the National Institute of Neurological Disorders and Stroke (NINDS), part of the Extramural Research Programs in the Neurosciences and Neurological Disorders (CFDA 93.853) program, provides $272,000.00 to the Rector & Visitors of the University of Virginia (UVA) from August 2024 through July 2029. The funding supports a Clinical Trials Methodology Course in Neurological Disorders that aims to train early-stage investigators and clinical biostatisticians to design and implement well-designed clinical trials and biomarker studies in neuroscience research. Key innovations include a focus on developing "fundable" grant proposals that can efficiently translate to competitive research applications, engaging with established NIH research networks, and incorporating practices to increase diversity, equity, inclusion, and community engagement. As a sub-award, Indiana University's Dr. Laurie Gutmann will serve as a Multiple Principal Investigator for 15% effort, managing program activities, recruitment, and the Foundation Track of the course.